Production (Stage)
Astrana Health, Inc.
ASTH
$24.29
-$0.18-0.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -58.38% | 102.04% | |||
| Total Other Revenue | -6.30% | 38.59% | |||
| Total Revenue | -6.74% | 38.96% | |||
| Cost of Revenue | -10.68% | 51.70% | |||
| Gross Profit | 41.30% | -31.31% | |||
| SG&A Expenses | 5.44% | 10.13% | |||
| Depreciation & Amortization | -15.71% | 11.87% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.73% | 47.57% | |||
| Operating Income | 2,758.75% | -97.47% | |||
| Income Before Tax | 606.81% | -107.07% | |||
| Income Tax Expenses | -42.49% | -24.89% | |||
| Earnings from Continuing Operations | 179.99% | -140.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -42.98% | 128.61% | |||
| Net Income | 196.27% | -143.19% | |||
| EBIT | 2,758.75% | -97.47% | |||
| EBITDA | 210.11% | -75.21% | |||
| EPS Basic | 192.07% | -144.44% | |||
| Normalized Basic EPS | 931.54% | -95.21% | |||
| EPS Diluted | 192.07% | -145.45% | |||
| Normalized Diluted EPS | 923.85% | -95.15% | |||
| Average Basic Shares Outstanding | 4.60% | -2.82% | |||
| Average Diluted Shares Outstanding | 5.42% | -3.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||